We are live on ! Find out more
NA

NewEdge Advisors Portfolio holdings

AUM $27.7B
1-Year Est. Return 22.98%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$8.85B
AUM Growth
+$851M
Cap. Flow
+$412M
Cap. Flow %
4.65%
Top 10 Hldgs %
16.84%
Holding
3,702
New
289
Increased
1,323
Reduced
1,138
Closed
218

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$30.8M
2
UL icon
Unilever
UL
+$28.5M
3
CMCSA icon
Comcast
CMCSA
+$27.6M
4
ITW icon
Illinois Tool Works
ITW
+$27.1M
5
MDLZ icon
Mondelez International
MDLZ
+$26.8M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$30.6M
2
ABT icon
Abbott
ABT
+$28.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.8M
4
DOV icon
Dover
DOV
+$27.1M
5
ULST icon
State Street Ultra Short Term Bond ETF
ULST
+$24.4M

Sector Composition

Rank Sector Weight
1 Technology 12.26%
2 Financials 5.78%
3 Healthcare 5.7%
4 Consumer Discretionary 4.46%
5 Industrials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOCS icon
3276
Doximity
DOCS
$3.82B
$816 ﹤0.01%
+24
New +$799
KYNB
3277
Kyntra Bio
KYNB
$27.5M
$810 ﹤0.01%
+12
New +$4.96K
GPMT
3278
Granite Point Mortgage Trust
GPMT
$64.7M
$774 ﹤0.01%
146
+6
+4% +$28
LUCK
3279
Lucky Strike Entertainment
LUCK
$959M
$769 ﹤0.01%
+66
New +$880
MT icon
3280
ArcelorMittal
MT
$52.3B
$766 ﹤0.01%
28
-5
-15% -$137
ALNY icon
3281
Alnylam Pharmaceuticals
ALNY
$27.4B
$760 ﹤0.01%
4
ELMD icon
3282
Electromed
ELMD
$333M
$760 ﹤0.01%
71
-13
-15% -$147
ARCT icon
3283
Arcturus Therapeutics
ARCT
$168M
$746 ﹤0.01%
26
ATS icon
3284
ATS Corp
ATS
$2.6B
$737 ﹤0.01%
+16
New +$719
HTZ icon
3285
Hertz
HTZ
$524M
$736 ﹤0.01%
40
MDVL
3286
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$736 ﹤0.01%
60
TDUP icon
3287
ThredUp
TDUP
$757M
$732 ﹤0.01%
300
-70
-19% -$183
CNSL
3288
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$728 ﹤0.01%
190
LL
3289
DELISTED
LL Flooring Holdings, Inc.
LL
$728 ﹤0.01%
190
-200
-51% -$773
EPP icon
3290
iShares MSCI Pacific ex Japan ETF
EPP
$2.25B
$718 ﹤0.01%
+17
New +$736
BKCC
3291
DELISTED
BlackRock Capital Investment Corporation
BKCC
$712 ﹤0.01%
217
BSY icon
3292
Bentley Systems
BSY
$10.7B
$705 ﹤0.01%
+13
New +$607
IBRX icon
3293
ImmunityBio
IBRX
$7.8B
$695 ﹤0.01%
250
EDR
3294
DELISTED
Endeavor Group Holdings, Inc.
EDR
$670 ﹤0.01%
+28
New +$660
NXDR
3295
Nextdoor Holdings
NXDR
$858M
$652 ﹤0.01%
200
EVR icon
3296
Evercore
EVR
$12.1B
$649 ﹤0.01%
5
IH
3297
iHuman
IH
$71M
$624 ﹤0.01%
+211
New +$654
GILT icon
3298
Gilat Satellite Networks
GILT
$830M
$623 ﹤0.01%
100
ZSTK
3299
ZeroStack Corp
ZSTK
$3.74M
$616 ﹤0.01%
7
NVVE
3300
DELISTED
Nuvve Holding Corp
NVVE
0

Similar funds

NewEdge Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, NewEdge Advisors held 3,702 positions worth $8.85B, up 11% from $8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

NewEdge Advisors deployed $412M of net new capital in Q2 2023, opening 289 new positions and adding to 1,323 existing holdings. Its largest new stake was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Accenture, an estimated $30.6M trimmed.

  • NewEdge Advisors's largest Q2 2023 buy was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
  • NewEdge Advisors added most to AbbVie in Q2 2023, an estimated $30.8M increase.
  • NewEdge Advisors's biggest Q2 2023 reduction was Accenture, cutting an estimated $30.6M.
  • NewEdge Advisors fully exited Quadratic Deflation ETF in Q2 2023, selling an estimated $3.13M.
  • NewEdge Advisors's ten largest holdings make up 17% of its $8.85B portfolio in Q2 2023.
  • NewEdge Advisors opened 289 new positions and closed 218 in Q2 2023.
  • NewEdge Advisors's portfolio value rose 11% quarter-over-quarter to $8.85B.

Based on NewEdge Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.